Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 2/2010

01.08.2010

High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model

verfasst von: K. Gopal, Kishor Kumar, R. Nandini, P. Jahan, M. J. Mahesh Kumar

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

We studied and compared the efficiency of induction aneurysm in apo E mice by using high fat diet and Ang II. Aneurysm induced in 6 week old male apo E −/− mice by subcutaneous release of Ang II injection for 45 days. Also, aneurysm was induced in three month old male apo E by administration of high fat diet for a period of three months. No difference in body weight in Ang II treated mice. But, increase in body weight and mean arterial blood pressure observed in high fat diet group animals. Highly significant increase in total cholesterol, TG, LDL and significant decrease in HDL level were observed in Ang II treated animals. Significant increase in total cholesterol, but no changes in TG, LDL, HDL levels were observed in high fat diet group. Higher percentage of circulating monocytes was observed in ang II treated group but more number of circulating lymphocytes were observed in high fat diet group in FACS analysis. In histopathology, intimal layer of abdominal aorta was completely replaced by chronic inflammatory cells particularly macrophages (80%) which appeared as foam cells and lymphocytes (20%) in ang II treated animals. Degradation of elastin, infiltration of lymphocytes, chondrocytes and cellular migration towards media were observed in the abdominal aorta of high fat diet group. Real time analysis and immunofluorescence assay supports over expression of Vcam 1 Icam1, MCP 1and MMP2 genes were observed in Ang II treated animals. In immunofluorescence assay, over expression of Mac 3 protein specific for macrophages was observed in abdominal aorta of ang II treated animals, but over expression of CD45.1 & 45.2 proteins specific to lymphocytes were observed in high fat diet group. Based on our observations, Ang II induced aortic aneurysm by recruiting/ proliferating circulating monocytes by up regulating Icam-1, Vcam -1 and MCP-1. Also, ang II involved in degradation of elastin in the abdominal aorta by up regulation of MMP2 to promote agranulocytes migration in the intimal layers. Epithelial cell hyperplasia with accumulation of fatty fluids (cyst) was observed in seminal vesicle and ventral prostate of high fat treated animals. Fatty degeneration, germ cell apoptosis and infiltration giant cells were observed in the testes of high fat diet group. As per available literature these observations were not reported with high fat diet treatments with apo E models. High fat diet induced aneurysm prominently in abdominal, thoracic aorta and extensive plaque formation was observed in femoral and renal arteries. Administration of high fat diet containing cholesterol induced aneurysm in apo E mice model also efficient method to rule out the pathogenesis of aortic aneurysm when compared with angiotensin.
Literatur
1.
Zurück zum Zitat Thompson RW, Baxter BT (1999) MMP inhibition in abdominal aortic aneurysms. Ann NY Acad Sci 878:159–178CrossRefPubMed Thompson RW, Baxter BT (1999) MMP inhibition in abdominal aortic aneurysms. Ann NY Acad Sci 878:159–178CrossRefPubMed
2.
Zurück zum Zitat Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Ballard DJ (1997) Prevalance and association of abdominal aortic aneurysm detected through screening: aneurysm detection and management (ADAM) veterans affair cooperative study group. Ann Intern Med 126:441PubMed Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Ballard DJ (1997) Prevalance and association of abdominal aortic aneurysm detected through screening: aneurysm detection and management (ADAM) veterans affair cooperative study group. Ann Intern Med 126:441PubMed
3.
Zurück zum Zitat Lintin MF, Fazio S (2001) Class A scavenger receptors. Macrophage and atherosclerosis. Curr Opin Lipidol 2:489–495CrossRef Lintin MF, Fazio S (2001) Class A scavenger receptors. Macrophage and atherosclerosis. Curr Opin Lipidol 2:489–495CrossRef
4.
Zurück zum Zitat Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 362:801–809CrossRefPubMed Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 362:801–809CrossRefPubMed
5.
Zurück zum Zitat Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2 −/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894–897CrossRefPubMed Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2 −/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894–897CrossRefPubMed
6.
Zurück zum Zitat Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V (2008) Angiotensin II amplifies macrophage-driven atherosclerosis. Arterioscler Thrombosis Vasc Biol 24:2143CrossRef Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V (2008) Angiotensin II amplifies macrophage-driven atherosclerosis. Arterioscler Thrombosis Vasc Biol 24:2143CrossRef
7.
Zurück zum Zitat Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275–281CrossRefPubMed Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275–281CrossRefPubMed
8.
Zurück zum Zitat Linton MF, Atkinson JB, Fazio S (1995) Prevention of atherosclerosis in apolipoprotein E deficient mice by bone marrow transplantation. Science 267:1034–11038CrossRefPubMed Linton MF, Atkinson JB, Fazio S (1995) Prevention of atherosclerosis in apolipoprotein E deficient mice by bone marrow transplantation. Science 267:1034–11038CrossRefPubMed
9.
Zurück zum Zitat Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF (1997) Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94:4647–4652CrossRefPubMed Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF (1997) Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94:4647–4652CrossRefPubMed
10.
Zurück zum Zitat Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL (2000) P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191:189–194CrossRefPubMed Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL (2000) P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191:189–194CrossRefPubMed
11.
Zurück zum Zitat Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM (1999) Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223–1229PubMed Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM (1999) Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223–1229PubMed
12.
Zurück zum Zitat Iademarco MF, McQuillan JJ, Rosen GD, Dean DC (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323–16329PubMed Iademarco MF, McQuillan JJ, Rosen GD, Dean DC (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323–16329PubMed
13.
Zurück zum Zitat Voraberger G, Schafer R, Stratowa C (1991) Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol 147:2777–2786PubMed Voraberger G, Schafer R, Stratowa C (1991) Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol 147:2777–2786PubMed
14.
Zurück zum Zitat Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T (1997) Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 272:31092–31099CrossRefPubMed Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T (1997) Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 272:31092–31099CrossRefPubMed
15.
Zurück zum Zitat Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI (2000) The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA 97:9052–9057CrossRefPubMed Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI (2000) The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA 97:9052–9057CrossRefPubMed
16.
Zurück zum Zitat Berk BC, Haendeler J, Sottile J (2000) Angiotensin II, atherosclerosis, and aortic aneurysms. J Clin Invest 105(11):1525–1526CrossRefPubMed Berk BC, Haendeler J, Sottile J (2000) Angiotensin II, atherosclerosis, and aortic aneurysms. J Clin Invest 105(11):1525–1526CrossRefPubMed
17.
Zurück zum Zitat Grange JJ, Davis V, Baxter BT (1997) Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cariovasc Surg 5:256–265CrossRef Grange JJ, Davis V, Baxter BT (1997) Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cariovasc Surg 5:256–265CrossRef
Metadaten
Titel
High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model
verfasst von
K. Gopal
Kishor Kumar
R. Nandini
P. Jahan
M. J. Mahesh Kumar
Publikationsdatum
01.08.2010
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 2/2010
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-010-0446-8

Weitere Artikel der Ausgabe 2/2010

Journal of Thrombosis and Thrombolysis 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.